News & Updates

Show Multimedia Only

Radiofrequency vs pulsed field ablation: Which approach results in fewer stroke/TIA events?

25 Apr 2026 by

A single-centre study has found a significantly higher incidence of stroke and transient ischaemic attacks (TIA) within 30 days among patients who underwent pulsed field ablation (PFA) relative to those who received radiofrequency ablation (RFA).

25 Apr 2026

Lowering BP threshold to 130/80 mm Hg enhances hypertension diagnosis

24 Apr 2026 by

A significant number of masked, sustained, and nighttime hypertension may not be detected when using the conventional home blood pressure (BP) threshold of 135/85 mm Hg, suggests a study.

24 Apr 2026

Statin-ezetimibe holds slight advantage over PCSK9is in ACS

24 Apr 2026 by

In a systematic review and network meta-analysis (NMA), a statin-ezetimibe combination yields a more favourable LDL-C reduction and a positive trend in atherosclerotic plaque regression compared with PCSK9 inhibitors (PCSK9is) alone in individuals with acute coronary syndrome (ACS).

24 Apr 2026

Pulsed field ablation helps prevent atrial tachyarrhythmia recurrence

23 Apr 2026

Pulsed field ablation (PFA) appears to reduce atrial tachyarrhythmia recurrence, and its use tends to lead to fewer redo ablations, a study in the Philippines has shown.

23 Apr 2026

Health supplements: Help or hype?

22 Apr 2026 by

A review of 19 meta-analyses shows mixed results on the effects of multivitamin and mineral (MVM) supplementation on health outcomes.

22 Apr 2026

Bax24 data boost baxdrostat potential for resistant HTN

21 Apr 2026 by

The results of the phase III Bax24 trial underpin the efficacy of baxdrostat, a selective aldosterone synthase inhibitor (ASI), for the treatment of uncontrolled or resistant hypertension (HTN).

21 Apr 2026

Study highlights potential link between VOCs and CVD, mortality

20 Apr 2026

Exposure to volatile organic compounds (VOCs) may be associated with increased risks of cardiovascular disease (CVD) and CVD death, as suggested in a systematic review and meta-analysis.

20 Apr 2026

Ultrasound-facilitated, catheter-directed thrombolysis beneficial in intermediate-risk PE

18 Apr 2026 by

In the treatment of patients with acute, intermediate-risk pulmonary embolism (PE), administering ultrasound-facilitated, catheter-directed thrombolysis (USCDT) on top of anticoagulation results in better short-term outcomes compared with anticoagulation alone, as shown in the multinational, adaptive-design, open-label HI-PEITHO trial.

18 Apr 2026

Transcatheter ViV may be a safe short-term option to repeat MVR

18 Apr 2026 by

The transcatheter valve-in-valve (ViV) procedure appears to be a safe option for select patients requiring repeat surgery after failed mitral bioprostheses, according to findings from the randomized controlled SURViV trial presented at ACC.26. However, it is still early days for the ViV approach.

18 Apr 2026

Methotrexate may lower CV risk in psoriasis patients

17 Apr 2026 by

Patients with psoriasis who are treated with methotrexate (MTX) show a reduced incidence of metabolic syndrome and better cardiometabolic profiles, according to a study presented at AAD 2026.

17 Apr 2026